tradingkey.logo

Masimo Corp

MASI
查看詳細走勢圖
134.040USD
-2.620-1.92%
收盤 12/19, 16:00美東報價延遲15分鐘
7.12B總市值
虧損本益比TTM

Masimo Corp

134.040
-2.620-1.92%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.92%

5天

-3.11%

1月

-6.27%

6月

-18.85%

今年開始到現在

-18.91%

1年

-20.93%

查看詳細走勢圖

TradingKey Masimo Corp股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Masimo Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名49/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價182.48。中期看,股價處於平穩狀態。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Masimo Corp評分

相關信息

行業排名
49 / 208
全市場排名
132 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 10 分析師
買入
評級
182.480
目標均價
+29.56%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Masimo Corp亮點

亮點風險
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
業績轉虧
公司業績轉虧,最新年度虧損美元
估值合理
公司最新PE估值-12.62,處於3年歷史合理位
機構減倉
最新機構持股60.04M股,環比減少6.78%
雷·達裡奧持倉
明星投資者雷·達裡奧持倉,最新持倉1.71K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.26

Masimo Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Masimo Corp簡介

Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
公司代碼MASI
公司Masimo Corp
CEOSzyman (Catherine M)
網址https://www.masimo.com/

常見問題

Masimo Corp(MASI)的當前股價是多少?

Masimo Corp(MASI)的當前股價是 134.040。

Masimo Corp 的股票代碼是什麼?

Masimo Corp的股票代碼是MASI。

Masimo Corp股票的52週最高點是多少?

Masimo Corp股票的52週最高點是194.880。

Masimo Corp股票的52週最低點是多少?

Masimo Corp股票的52週最低點是132.900。

Masimo Corp的市值是多少?

Masimo Corp的市值是7.12B。

Masimo Corp的淨利潤是多少?

Masimo Corp的淨利潤為-304.90M。

現在Masimo Corp(MASI)的股票是買入、持有還是賣出?

根據分析師評級,Masimo Corp(MASI)的總體評級為買入,目標價格為182.480。

Masimo Corp(MASI)股票的每股收益(EPS TTM)是多少

Masimo Corp(MASI)股票的每股收益(EPS TTM)是-10.624。
KeyAI